OncoRedox
Point-of-care Testing Device for Cancer Detection
StartupOncoRedox is a Or Yehuda-based startup in the Health Tech & Life Sciences sector, established in 2022. Point-of-care Testing Device for Cancer Detection. The company has raised a total of $890K across 1 funding round, currently at the Seed stage. Key investors include Peregrine Ventures. The company has 1-10 employees. Core technologies: Artificial Intelligence, Biologicals.
With $890K in total funding, OncoRedox is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: R&D.
- StageSeed
- ProductR&D
- ModelB2B
- Employees1-10
- HQOr Yehuda
- Last Round$890K
- Peregrine VenturesLead
What does OncoRedox do?
OncoRedox is developing a Point-of-care testing device for cancer detection based on ‘Redox-omics’ analysis of urine samples. The technology is based on biochemical electrodes detecting redox metabolic signature using an AI analysis model.
How much funding has OncoRedox raised?
OncoRedox has raised $890K in total funding across 1 rounds. The company is currently at the Seed stage. Key investors include Peregrine Ventures.
What sector is OncoRedox in?
OncoRedox operates in Health Tech & Life Sciences, Medical Devices, Diagnostics Devices, with core technologies in Artificial Intelligence, Biologicals. Target customers: Healthcare & Life Sciences, Healthcare, Providers.
Where is OncoRedox located?
OncoRedox is based in Or Yehuda, Israel.